Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (641-650 of 692) with videos related to

Pageof 70
Sort By:
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
The New England Journal of Medicine|May 27, 2011
Abiraterone and increased survival in metastatic prostate cancerJohann S de Bono, Christopher J Logothetis, Arturo Molina, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative <sup>18</sup>F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Pageof 70

Showing results (641-650 of 692) with videos related to

Sort By:
Pageof 70
JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
The New England Journal of Medicine|May 27, 2011
Abiraterone and increased survival in metastatic prostate cancerJohann S de Bono, Christopher J Logothetis, Arturo Molina, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative <sup>18</sup>F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Pageof 70